Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: Anti-tumor activity and peripheral blood progenitor cell mobilization capability

Breast Cancer Research and Treatment

Volumn 82, Issue 3, 2003, Pages 185-190

  Ballestrero, Alberto ^a   Montemurro, Filippo ^b   Gonella, Roberta ^a   Capaldi, Antonio ^b   Danova, Marco ^c   Friedman, Daniele ^a   Puglisi, Maria ^a   Aglietta, Massimo ^b   Patrone, Franco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Breast neoplasms; Granulocyte colony stimulating factor; Hematopoietic stem cell mobilization; Metastatic; Paclitaxel; Vinorelbine

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; NAVELBINE; PACLITAXEL;

ADULT; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; BREAST CANCER; CELL MOTILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG SAFETY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; LYMPHOCYTOPENIA; METASTASIS; MUCOSA INFLAMMATION; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; TREATMENT OUTCOME; VINBLASTINE;

EID: 0346221273     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000004374.72658.17     Document Type: Article

References (21)

1. Vogel CL, Nabholtz JM: Monotherapy of metastatic breast cancer: a review of newer agents. Oncologist 4: 17-33, 1999
2. Knick VC, Eberwein DJ, Miller CG: Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells. J Natl Cancer Inst 87: 1072-1077, 1995
3. Kano Y, Akutsu M, Suzuki K, Ando J, Tsunoda S: Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro. Breast Cancer Res Treat 56: 79-90, 1999
4. Livingston RB, Ellis GK, Gralow JR, Williams MA, White R, McGuirt C, Adamkiewicz BB, Long CA: Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 15: 1395-1400, 1997
5. Ellis GK, Gralow JR, Pierce HI, Williams MA, Livingston RB: Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients. J Clin Oncol 17: 1407-1412, 1999
6. Romero AL, Langhi M, Perez J, Romero AJ, Machiavelli M, Lacava J, Vallejo C, Romero A, Fasce H, Ortiz E, Grasso S, Amato S, Rodriguez R, Barbieri M, Leone B: Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer. J Clin Oncol 17: 74-81, 1999
7. Vici P, Amodio A, Di Lauro L, Conti F, Gionfra T, Belli F, Lopez M: First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer. Oncology 58: 3-7, 2000
8. Martin M, Lluch A, Casado A, Garciia CI, de Paz L, Esteban C, Insa A, Alfonso R, Garcia-Conde J, Diaz-Rubio E: Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure. Ann Oncol 11: 85-89, 2000
9. Ibrahim NK, Buzdar AU, Valero V, Dhingra K, Willey J, Hortobagyi GN: Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma. Cancer 91: 664-671, 2001
10. Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN: Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 6: 133-146, 2001
11. Fossati R, Confalonieri C, Torri V, Ghislandi E, Penna A, Pistotti V, Tinazzi A, Liberati A: Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol 16: 3439-3460, 1998
12. Norton L: Evolving concepts in the systemic drug therapy of breast cancer. Semin Oncol 24: S10-S10, 1997
13. World Health Organization: Handbook for Reporting Results of Cancer Treatment. WHO, Geneva, 1979
14. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207-214, 1981
15. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stem AC, Lansdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400-409, 1991
16. Miettinen OS: Estimation of relative risk from individually matched series. Biometrics 26: 75-86, 1970
17. Biganzoli L, Cufer T, Bruning P, Coleman R, Duchateau L, Calvert AH, Gamucci T, Twelves C, Fargeot P, Epelbaum R, Lohrisch C, Piccart MJ: Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. J Clin Oncol 20: 3114-3121, 2002
18. Demirer T, Rowley S, Buckner CD, Appelbaum FR, Lilleby K, Storb R, Schiffman K, Bensinger WI: Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J Clin Oncol 13: 1714-1719, 1995
19. Pedrazzoli P, Perotti C, Da Prada GA, Bertolini F, Gibelli N, Torretta L, Battaglia M, Pavesi L, Preti P, Salvaneschi L, Robustelli della CG: Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer. Br J Cancer 75: 1368-1372, 1997
20. Baynes RD, Dansey RD, Klein JL, Karanes C, Cassells L, Abella E, Wei WZ, Galy A, Du W, Wood G, Peters WP: High-dose chemotherapy and autologous stem cell transplantation for breast cancer. Cancer Invest 18: 440-455, 2000
21. Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy Jr. PL, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM: High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B Trials with data from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 20: 743-750, 2002